James Kang
AstraZeneca
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by James Kang.
Bioorganic & Medicinal Chemistry Letters | 2010
Hui Xiong; Todd Andrew Brugel; Michael Balestra; Dean G. Brown; Kelly Brush; Caprice Hightower; Lindsay Hinkley; Valerie Hoesch; James Kang; Gerard M. Koether; John P. McCauley; Francis M. McLaren; Laura M. Panko; Thomas R. Simpson; Reed W. Smith; James Woods; Becky Brockel; Vijay Chhajlani; Reto Gadient; Nathan Spear; Linda A. Sygowski; Minli Zhang; Jalaj Arora; Nathalie Breysse; Julie Wilson; Methvin Isaac; Abdelmalik Slassi; Megan M. King
Positive allosteric modulation of metabotropic glutamate receptor 5 (mGluR5) is regarded as a potential novel treatment for schizophrenic patients. Herein we report the synthesis and SAR of 4-aryl piperazine and piperidine amides as potent mGluR5 positive allosteric modulators (PAMs). Several analogs have excellent activity and desired drug-like properties. Compound 2b was further characterized as a PAM using several in vitro experiments, and produced robust activity in several preclinical animal models.
Bioorganic & Medicinal Chemistry Letters | 2011
Hui Xiong; James Kang; James Woods; John P. McCauley; Gerard M. Koether; Jeffrey S. Albert; Lindsay Hinkley; Yan Li; Reto Gadient; Thomas R. Simpson
The neurokinin-3 (NK3) receptor is regarded as a potential novel target for treating patients with schizophrenia. Herein we report the synthesis and SAR of a series of C3-alkylsulfoxide substituted quinolines as potent NK3 receptor antagonists. These compounds have excellent NK3 functional activity, good selectivity and drug-like properties. Several key compounds have good in vitro/in vivo DMPK characteristics, and are active in a gerbil locomotor activity model.
Archive | 2003
Christopher Becker; Bruce AstraZeneca Wilmington Dembofsky; Robert AstraZeneca Wilmington Jacobs; James Kang; Cyrus AstraZeneca Wilmington Ohnmacht; James Rosamond; Ashokkumar Bhikkappa Shenvi; Thomas AstraZeneca Wilmington Simpson; James AstraZeneca Wilmington Woods
Archive | 2007
Jeffrey S. Albert; Cristobal Alhambra; James Kang; Gerard M. Koether; Yan Li; Thomas R. Simpson; James Woods
Archive | 2006
Jeffrey S. Albert; Cristobal Alhambra; James Kang; Gerard M. Koether; Thomas R. Simpson; James Woods; Yan Li
Archive | 2008
Thomas R. Simpson; James Kang; Jeffrey S. Albert; Cristobal Alhambra; Gerard M. Koether; James Woods; Yan Li
Archive | 2006
Jeffrey S. Albert; Cristobal Alhambra; James Kang; Gerard M. Koether; Thomas R. Simpson; James Woods; Yan Li
Archive | 2006
Thomas R. Simpson; Michael Balestra; Dean G. Brown; Cathy Dantzman; Glen Ernst; William Frietze; Christopher R. Holmquist; James Kang; Frances M. Mclaren; Reed W. Smith; James Woods
Archive | 2006
R. Thomas AstraZeneca Wilmington Simpson; James Kang; S. Jeffrey AstraZeneca Wilmington Albert; Cristobal Alhambra; M. Gerard Koether; M. James Woods; Yan AstraZeneca Wilmington Li
Archive | 2006
Jeffrey S. Albert; Gerard M. Koether; Cristobal Alhambra; James Kang; Thomas R. Simpson; James Woods; Yan Li